The 57th ASH Annual Meeting & Exposition is less than two months away. This is the premier event in malignant and non-malignant hematology, where attendees will have the opportunity to review more than 3,000 scientific abstracts highlighting the updates in the hottest topics in hematology, interact with the global community of more than 20,000 hematology professionals from every subspecialty, attend the hallmark Education and Scientific Program sessions, and network with top minds in the field.
Dates to Keep in Mind
- Call for Late-Breaking Abstract submissions: October 22-29
- Advanced registration deadline: November 4
- Abstracts available online: November 5
Get Your Blood Racing in Support of the Future of Hematology
If you have not already done so, consider registering for the ASH Foundation Run/Walk on Sunday, December 6. Join fellow ASH meeting attendees, including Carol O’Hear, for the Run/Walk along Universal Boulevard in Orlando. You can choose a 3K or 5K route, donate, and fundraise as an individual, with colleagues as a team, or as a sponsor for other participants such as trainees. Friends and family can support your efforts by donating in honor of you or your team! To register and/or donate, please go to webapps.hematology.org/runwalk.
View Educational Content from the ASH Meeting on Hematologic Malignancies
Whether or not you attended the ASH Meeting on Hematologic Malignancies in Chicago last month, you can pre-order the webcast and receive more than 15 hours of exclusive educational content. The webcast provides access to 25 sessions and 9 panel discussions featuring top experts in hematologic malignancies, including leukemia, lymphoma, myelodysplastic syndromes, myeloma, and myeloproliferative neoplasms. The content will feature evidence-based treatment approaches, ranging from standard of care, specialized disease complications, and novel agent discussions.
Go to ashondemand.org/Meeting/102935274 to preorder this educational product.
Save the Date: 2016 ASH Meeting on Lymphoma Biology
The ASH Meeting on Lymphoma Biology will be held June 18-21, 2016, at the Broadmoor in Colorado Springs, Colorado. The goal of the meeting is to further the understanding of lymphoma pathogenesis and accelerate new therapies by providing a forum for scientific exchange and networking opportunities for the lymphoma community. The meeting’s objectives include:
- Establish a forum for the exchange of the state-of-science in basic and translational lymphoma research
- Encourage networking among lymphoma researchers to enable more collaboration and synergy in the field
- Foster collaboration and sharing of data and reagents among lymphoma researchers
- Support relationships between academia and industry focused on chemical biology, immunotherapy, and other therapeutic approaches in the area of lymphoma
The target audience for this meeting includes laboratory-based scientists, translational investigators, pharmaceutical scientists, and others interested in lymphoma science. The three-day meeting will include didactic sessions, abstract presentations, and interactive workshops/panel discussions.
Michael Stratton, MBBS, PhD
Wellcome Trust Sanger Institute, Cambridge, United Kingdom
Topic: Genetics of Cancer
Hao Wu, PhD
Boston Children’s Hospital, Boston, MA
Topic: Elucidation of Macromolecular Interactions Using Structural Biology